Constarium
← Search

Omics · study · 2026

ATACseq of ENTPD1/CD39 and NT5E/CD73 in A549 human NSCLC cell lines

Listed in NCBI GEO

There is a highlighted need to understand properties of the CD39/CD73 pathway in human lung malignancies considering recent clinical trials demonstrating prominent anti-tumor activity of CD73-blocking antibodies in combination with PD-L1 antagonists.

Description

To establish if proinflammatory cytokines commonly upregulated in the inflamed TME could modulate CD39 and CD73 expression levels, we exposed cultured human A549 lung ADC cells to IFNγ and TNFα and found an induction of CD73 protein expression.

Using ATAC-seq, we analyzed DNA extracted from these control and treated cell preparations, with the goal to explore mechanisms underlying the increased CD73 expression in proinflammatory states.

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Provenance · 1 source records, 7 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE34711013 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:genome-binding-occupancy-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title